Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome

NCT: NCT04734847 · ACTIVE_NOT_RECRUITING

NCT IDNCT04734847
StatusACTIVE_NOT_RECRUITING
Start Date2021-06-01
Completion2026-10-30
SponsorUniversity of Southern California (OTHER)
First posted
Last updated

Brief Summary

Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) is a common, chronic, and debilitating condition in women. Preliminary evidence suggests that IC/BPS pain can be reduced applying non-invasive repetitive transcranial magnetic stimulation (rTMS) to areas of the brain that regulate pelvic floor muscle activity. However, prior studies have examined rTMS in a very limited sample and have not examined changes in brain or pelvic floor muscle activity to determine the mechanism of rTMS for IC/BPS. This study is designed to directly address these limitations.

Frequently Asked Questions

What is Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome?

Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome is a clinical trial registered under NCT04734847. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04734847?

The current status of NCT04734847 (Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome) is: ACTIVE_NOT_RECRUITING.

When did Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome start?

Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome started on 2021-06-01.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.